Clinical Trials on Unilineage Bone Marrow Failure Disorders in United Kingdom
Total 4699 results
-
Washington University School of MedicineTakedaTerminatedMyelofibrosesUnited States
-
BioCryst PharmaceuticalsCompletedParoxysmal Nocturnal HemoglobinuriaUnited Kingdom, Austria, South Africa
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential ThrombocythemiaUnited States
-
Gilead SciencesCalifornia Institute for Regenerative Medicine (CIRM)CompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited Kingdom
-
Imperial College Healthcare NHS TrustCompletedGraft Rejection | End-stage Renal FailureUnited Kingdom
-
Zimmer BiometCompletedBone Marrow EdemaUnited States
-
Ascentage Pharma Group Inc.WithdrawnMyelofibrosisUnited States
-
Nottingham University Hospitals NHS TrustUniversity of Nottingham; University of Sheffield; Sheffield Teaching Hospitals...CompletedNutrition Aspect of Cancer | Stem Cell Transplant Complications | Prehabilitation | Haematological Malignancy | Nutritional and Metabolic Disease | Bone Marrow Transplant Complications | Exercise InterventionsUnited Kingdom
-
M.D. Anderson Cancer CenterActive Biotech ABNot yet recruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-Essential Thrombocytosis MyelofibrosisUnited States
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential ThrombocythemiaUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Celgene; Incyte CorporationActive, not recruitingMyelofibrosisUnited States
-
Washington University School of MedicineRigel PharmaceuticalsTerminatedMyelofibrosis | ThrombocytopeniaUnited States
-
Roswell Park Cancer InstituteCompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Myelodysplastic/Myeloproliferative Diseases | Nonmalignant NeoplasmUnited States
-
The Emmes Company, LLCNational Heart, Lung, and Blood Institute (NHLBI)TerminatedStudy of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated DonorLymphoma | Hodgkin Disease | Myelofibrosis | Anemia, Aplastic | Leukemia, Lymphocytic, Acute | Leukemia, Myelocytic, Acute | Leukemia, Myeloid, Chronic | Leukemia, Lymphocytic, ChronicUnited States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdRecruiting
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Loughborough UniversityCompletedBone Resorption | Energy Supply; Deficiency | Female Athlete Triad | Relative Energy Deficiency in Sport | Bone AtrophyUnited Kingdom
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumCompletedPolycythemia Vera | Essential Thrombocythemia | Idiopathic MyelofibrosisUnited States, Italy
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Fanconi Anemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host Disease | Diamond-blackfan AnemiaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
University of California, IrvineCompletedMyeloproliferative NeoplasmUnited States
-
M.D. Anderson Cancer CenterCTI BioPharmaTerminatedMyeloproliferative DiseasesUnited States
-
John MascarenhasNational Cancer Institute (NCI); Incyte Corporation; Myeloproliferative Disorders-Research...CompletedMyeloproliferative NeoplasmsUnited States
-
Incyte CorporationCompletedMyelofibrosisUnited States
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia VeraAustralia, Austria, Belgium, China, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Ireland, United Kingdom
-
M.D. Anderson Cancer CenterCephalonCompleted
-
Ronald HoffmanNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumUnknownPolycythemia Vera | Essential Thrombocythemia | MyelofibrosisUnited States
-
Cell Medica LtdUniversity College, London; Cell Therapy CatapultCompletedAcute Myeloid Leukaemia | Chronic Myeloid LeukaemiaUnited Kingdom
-
Synta Pharmaceuticals Corp.CompletedMyeloproliferative Disorders | AML | MDS | CMLUnited States
-
Medical Research CouncilCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited Kingdom
-
CelgeneRecruitingPrimary Myelofibrosis | Myeloproliferative Disorders | Anemia | Myelofibrosis | Post-Polycythemia Vera MyelofibrosisFrance, Belgium, Spain, Australia, Canada, United States, Korea, Republic of, Romania, Japan, Israel, Italy, Austria, China, Czechia, Germany, Greece, Ireland, Poland, United Kingdom, Hong Kong, Hungary, Lebanon, Colombia, Argentina, Chile and more
-
PharmaMarCompletedMyelofibrosisUnited States, Italy
-
University Hospital Southampton NHS Foundation...Genzyme, a Sanofi CompanyCompletedMyelodysplasia | Acute Myeloid LeukaemiaUnited Kingdom
-
AbbVieActive, not recruitingMyeloproliferative NeoplasmUnited States, Belgium, Bulgaria, Croatia, France, Germany, Italy, Japan, Serbia, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
Vanderbilt UniversityNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Nonmalignant Neoplasm | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative Neoplasms | MethemoglobinemiaUnited States
-
Medical Research CouncilCompletedMyelodysplastic Syndromes | LeukemiaUnited Kingdom
-
M.D. Anderson Cancer CenterRecruitingPrimary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Myelofibrosis Transformation in Essential ThrombocythemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Secondary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis PhaseUnited States
-
John MascarenhasTerminatedPrimary Myelofibrosis | Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Post-essential Thrombocythemia Related MyelofibrosisUnited States
-
University of DundeeCompleted
-
Barts & The London NHS TrustCompletedChronic Ischaemic Heart FailureUnited Kingdom
-
King's College LondonCompletedNeonatal Respiratory FailureUnited Kingdom
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis (PMF) | Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) | Post-polycythemia Vera (Post-PV)United States, Canada, France, Italy, Germany, Spain, Israel, United Kingdom
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis (PMF) | Post Polycythaemia Myelofibrosis (PPV MF) | Post Essential Thrombocythaemia Myelofibrosis (PET-MF)United Kingdom
-
King's College Hospital NHS TrustTerminatedLymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Hodgkin Disease | Chronic Lymphocytic Leukemia | Leukemia, Lymphoblastic, AcuteUnited Kingdom
-
Eli Lilly and CompanyCompletedPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myeloproliferative Neoplasms ofUnited States
-
Geron CorporationRecruiting
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumCompletedPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Idiopathic MyelofibrosisUnited States, Italy
-
National Institutes of Health Clinical Center (CC)CompletedPolycythemia Vera | Chronic Myeloproliferative Disorders | Essential Thrombocytosis | Idiopathic Myelofibrosis | NeutrophilsUnited States